EUVIMEDEUVIMED entdecken
Crossref

Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty

Andriy Kobryn iD, Edward M Schwarz iD

JBJS Case Connector · 2026-10 · 16 (4)

DOI: 10.2106/jbjs.cc.26.00129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JBJS Case Connector, 2026-10. Verfasst von Andriy Kobryn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

food allergyhypersensitivityomalizumabperioperative

Autor:innen und Institutionen

  • Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York.
  • Department of Orthopaedics and Physical Performance, University of Rochester Medical Center, Rochester, New York.

ORCID-Profile: Andriy Kobryn, Edward M Schwarz

Zitieren

APA

Kobryn, A., & Schwarz, E. M. (2026). Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty. JBJS Case Connector, 16(4). https://doi.org/10.2106/jbjs.cc.26.00129

Vancouver

Kobryn A, Schwarz EM. Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty. JBJS Case Connector. 2026;16(4). doi:10.2106/jbjs.cc.26.00129

BibTeX
@article{Kobryn2026,
  author = {Kobryn, Andriy and Schwarz, Edward M},
  title = {Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty},
  journal = {JBJS Case Connector},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.2106/jbjs.cc.26.00129}
}
Kostenlos starten →